NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES EARLY DECLARATION OF REGULAR MONTHLY DISTRIBUTION

NEW YORK, March 12, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced an early declaration of the Fund's regular monthly distribution payable in April. The $0.0905 per share of common stock distribution announced today is payable on April 30, 2026, has a record date of April 7, 2026, and has an ex-date of April 7, 2026.

PRNewsWire • Mar 12, 2026

NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES RIGHTS OFFERING AND SUMMARY OF TERMS

NEW YORK, March 12, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced approval of the terms of the issuance of transferable rights ("Rights") to the holders of the Fund's common stock (par value $0.0001 per share) ("Common Stock"), as of the record date, March 23, 2026 (the "Record Date"). Holders of these Rights will be entitled to subscribe for additional shares of Common Stock (the "Offer") at a discount to market price.

PRNewsWire • Mar 12, 2026

NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION

NEW YORK, Feb. 27, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on March 31, 2026, has a record date of March 16, 2026, and has an ex-date of March 16, 2026.

PRNewsWire • Feb 27, 2026

NHS: Dividend Isn't Supported By Earnings

Neuberger High Yield Strategies remains rated Hold due to persistent NAV declines and inadequate dividend coverage. NHS's 14.9% yield is attractive, but net investment income consistently falls short of distributions, increasing reliance on volatile realized gains. Leverage at 30% of assets amplifies both yield and risk, especially amid high interest rates and a predominantly below-investment-grade portfolio.

Seeking Alpha • Jan 19, 2026

NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND ANNOUNCES CHANGES TO PORTFOLIO MANAGEMENT TEAM

NEW YORK , Dec. 15, 2025 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced that Joseph Lind, co-Portfolio Manager to the Fund, will expand his role and become Co-Head of Special Situations effective December 31, 2025, and will cease his portfolio management responsibilities to the Fund on or about December 31, 2026. Steve Ruh, CFA, Managing Director, has been named co-Portfolio Manager of the Fund, effective December 31, 2025.

PRNewsWire • Dec 15, 2025

NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION

NEW YORK , Nov. 28, 2025 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on December 31, 2025, has a record date of December 15, 2025, and has an ex-date of December 15, 2025.

PRNewsWire • Nov 28, 2025

NHS: Caution Is Advised For This High-Yielding Bond CEF

Neuberger Berman High Yield Strategies Fund (NHS) offers a 14.76% yield, the highest among junk bond funds, attracting income-focused investors. NHS fails to fully cover its distribution from net investment income, leading to net asset value erosion and raising concerns about distribution sustainability. Despite its high yield, NHS underperforms most peers on total return and currently trades at a premium to net asset value, making it expensive relative to alternatives.

Seeking Alpha • Oct 27, 2025

NHS: Hold Given Narrowing Margin Of Safety And Rising Consumer Credit Risks

Neuberger Berman High Yield Strategies is a leveraged closed-end fund focused on high-yield bonds, offering income and NAV growth through active management. Current market conditions favor carry income, but rising consumer delinquency rates signal potential risk for high-yield spreads and leveraged CEFs like NHS. While the fund's diversified portfolio and liquidity are strengths, increasing credit card and auto loan delinquencies warrant caution for new buyers.

Seeking Alpha • Aug 14, 2025

NHS: Double-Digit Yielding Bond Fund Suppressed By Higher Rates

NHS provides a high 14.7% yield by investing in below investment grade debt, but this comes with elevated risk and price volatility. The fund's NAV and price have steadily declined, reflecting sensitivity to high interest rates and aggressive leverage use. Dividend sustainability is questionable, as earnings often fail to cover distributions, risking further NAV erosion if payouts aren't reduced.

Seeking Alpha • May 29, 2025

4 CEFs To Consider For Your High-Yield Income Compounder Portfolio

Heightened market volatility offers unique buying opportunities for income investors, particularly in high-yield income funds like CEFs and ETFs, ideal for retirement portfolios. CEFs are attractive due to their potential to trade at a discount, leverage to magnify returns, and managed distribution policies, despite the misunderstood concept of return of capital. Four recommended CEFs—OPP, CCIF, NHS, and ECAT—offer high yields and are suited for different economic scenarios, providing diverse options for income compounder portfolios.

Seeking Alpha • Apr 25, 2025